Application of Biological Agents in Treatment of Perianal Fistulizing Crohn's Disease / 胃肠病学
Chinese Journal of Gastroenterology
; (12): 626-629, 2018.
Article
en Zh
| WPRIM
| ID: wpr-698216
Biblioteca responsable:
WPRO
ABSTRACT
Perianal fistulizing Crohn's disease (pfCD)often indicates aggressive and refractory phenotype. Two-thirds of the patients with pfCD will relapse,so the treatment is really challenging. Currently,biological agents have made great progress. The application of biological agents such as infliximab brings new hope to the treatment of pfCD. This article reviewed the application of biological agents in treatment of pfCD.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Gastroenterology
Año:
2018
Tipo del documento:
Article